143 related articles for article (PubMed ID: 28989042)
1. Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug.
Zhong S; Wu B; Dong X; Han Y; Jiang S; Zhang Y; Bai Y; Luo SX; Chen Y; Zhang H; Zhao G
World Neurosurg; 2018 Jan; 109():e329-e342. PubMed ID: 28989042
[TBL] [Abstract][Full Text] [Related]
2. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. Identification of Driver Genes and Key Pathways of Pediatric Brain Tumors and Comparison of Molecular Pathogenesis Based on Pathologic Types.
Zhong S; Wu B; Han Y; Cao Y; Yang L; Luo SX; Chen Y; Zhang H; Zhao G
World Neurosurg; 2017 Nov; 107():990-1000. PubMed ID: 28751139
[TBL] [Abstract][Full Text] [Related]
5. Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma.
Zeng J; Hua S; Liu J; Mungur R; He Y; Feng J
Front Genet; 2022; 13():928407. PubMed ID: 36238156
[No Abstract] [Full Text] [Related]
6. Identification of driver genes and key pathways of prolactinoma predicts the therapeutic effect of genipin.
Zhong S; Wu B; Wang X; Sun D; Liu D; Jiang S; Ge J; Zhang Y; Liu X; Zhou X; Jin R; Chen Y
Mol Med Rep; 2019 Sep; 20(3):2712-2724. PubMed ID: 31322266
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
8. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.
Xu P; Zhang G; Hou S; Sha LG
Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis and verification of molecular genetic targets for glioblastoma.
Xue L; Liu H; Chen Y; Wei L; Hong J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
11. Aurora kinase A as a rational target for therapy in glioblastoma.
Barton VN; Foreman NK; Donson AM; Birks DK; Handler MH; Vibhakar R
J Neurosurg Pediatr; 2010 Jul; 6(1):98-105. PubMed ID: 20593995
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.
Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M
Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182
[TBL] [Abstract][Full Text] [Related]
13. Screening prognosis-related genes in glioblastoma by microarray analysis.
Wang H; Zhang Y; Zhang C; Tong X
Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar and Spindle Associated Protein 1 (NUSAP1) Inhibits Cell Proliferation and Enhances Susceptibility to Epirubicin In Invasive Breast Cancer Cells by Regulating Cyclin D Kinase (CDK1) and DLGAP5 Expression.
Zhang X; Pan Y; Fu H; Zhang J
Med Sci Monit; 2018 Nov; 24():8553-8564. PubMed ID: 30476929
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
[TBL] [Abstract][Full Text] [Related]
16. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
Dong C; Fan W; Fang S
J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
[TBL] [Abstract][Full Text] [Related]
17. Selected by gene co-expression network and molecular docking analyses, ENMD-2076 is highly effective in glioblastoma-bearing rats.
Zhong S; Bai Y; Wu B; Ge J; Jiang S; Li W; Wang X; Ren J; Xu H; Chen Y; Zhao G
Aging (Albany NY); 2019 Nov; 11(21):9738-9766. PubMed ID: 31706255
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
19. miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.
Qiao W; Guo B; Zhou H; Xu W; Chen Y; Liang Y; Dong B
Biochem Biophys Res Commun; 2017 Apr; 486(1):43-48. PubMed ID: 28242198
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
